5 completed, 1 recruiting. 3 Phase 3, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Breast Cancer Female NOS: new trials by email Literature Review of Breast Cancer Female NOS trials Research Report on Breast Cancer Female NOS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of an Educational Intervention in Women With Breast Cancer (EDU-INT-BC) Therapeutic Education Program for Women With Breast Cancer - Breast Cancer Female NOS | Not applicable | Completed | Instituts Supérieurs des Professions Infirmières et Techniques de Santé, Morocco | 62 | 2026-01-26 | 2026-06-10 |
| Psychological State, Immunotherapy Response, and Multi-Omics Signatures in TNBC Breast Cancer Female NOS, General Anxiety Disorder | Recruiting | Fudan University | 120 | 2026-01-01 | 2025-12-18 | |
| Denosumab as an add-on Neoadjuvant Treatment (GeparX) Denosumab, nab-Paclitaxel, Epirubicin - Breast Cancer Female NOS, Tubular Breast Cancer Stage II | Phase 2 | Completed | GBG Forschungs GmbH | 780 | 2017-02-13 | 2021-02-02 |
| A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) non-pegylated liposomal doxorubicin, Carboplatin, Paclitaxel - Tubular Breast Cancer Stage II, Tubular Breast Cancer Stage III | Phase 3 | Completed | GBG Forschungs GmbH | 961 | 2014-12-01 | 2017-07-13 |
| Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) nab-Paclitaxel, Paclitaxel - Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II | Phase 3 | Completed | GBG Forschungs GmbH | 1229 | 2012-07-01 | 2020-08-06 |
| Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer Carboplatin, background treatment - Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II | Phase 2 / Phase 3 | Completed | GBG Forschungs GmbH | 595 | 2011-08-01 | 2016-02-15 |
Carcinoma, Ductal, Breast (4) · Inflammatory Breast Neoplasms (4) · Breast Neoplasms (2) · Depressive Disorder (1) · Generalized Anxiety Disorder (1) · Treatment Adherence and Compliance (1)
Breast Diseases (6) · Neoplasms (6) · Neoplasms by Site (6) · Skin Diseases (6) · Skin and Connective Tissue Diseases (6) · Adenocarcinoma (4) · Breast Neoplasms (4) · Carcinoma (4) · Carcinoma, Ductal (4) · Neoplasms by Histologic Type (4) · Neoplasms, Ductal, Lobular, and Medullary (4) · Neoplasms, Glandular and Epithelial (4) · Anxiety Disorders (1) · Behavior (1) · Health Behavior (1)
Carboplatin (3) · Paclitaxel (3) · 130-nm albumin-bound paclitaxel (2) · Albumin-Bound Paclitaxel (2) · Cyclophosphamide (2) · Doxorubicin (2) · Epirubicin (2) · Trastuzumab (2) · pertuzumab (2) · Bevacizumab (1) · Denosumab (1) · Lapatinib (1) · ferric carboxymaltose (1)
GBG Forschungs GmbH (4) · Fudan University (1) · Instituts Supérieurs des Professions Infirmières et Techniques de Santé, Morocco (1)
Germany (4) · China (1) · Morocco (1)
Andreas Schneeweiss, MD, Prof. (1) · Gunter von Minckwitz, MD, Prof (1) · Jens Uwe Blohmer, MD (1) · Michael Untch, Prof MD (1)
PMID 34252375, PMID 24794243, PMID 25199759, PMID 25534375, PMID 26869049, PMID 28315068, PMID 28715532, PMID 30528802, PMID 32163106, PMID 33191846, PMID 34801353, PMID 35588050, PMID 37014668, PMID 38979716